| Seno Medical |
| Janet Campbell CEO |
| http://www.senomedical.com/ |
| Medical Device |
| Cancer diagnostic |
| Seno Medical, Inc. was formed to commercialize a new modality in cancer screening and diagnosis: laser opto-acoustic imaging. Unlike most screening techniques, which rely on anatomical imaging, Seno's goal is to bring functional imaging that can detect angiogenesis to the marketplace. Our first product is a small animal imaging device, now in testing and scheduled for release in spring 2007. Products for use with humans, focusing initially on breast cancer, are also in development for subsequent testing.
A strong, experienced management team and nationally recognized Scientific Advisory Board have been assembled to complete the commercialization, secure regulatory approval and launch the products. The management team has a long history of working together and in successfully commercializing medical devices.
Seno’s patented technology integrates the use of lasers and acoustics to determine the presence of angiogenesis—the growth of blood vessels and higher blood volume that always surrounds a tumor. This represents a significant evolutionary step in imaging. Unlike anatomical imaging techniques, such as mammography, laser opto-acoustic imaging can detect breast cancer, for example, at its earliest clinically significant stage (2 mm. versus 10 mm. with mammography) without patient discomfort or exposure to harmful x-ray. |
